Back to Search
Start Over
Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia.
- Source :
-
Blood cancer journal [Blood Cancer J] 2018 Aug 22; Vol. 8 (9), pp. 80. Date of Electronic Publication: 2018 Aug 22. - Publication Year :
- 2018
- Subjects :
- Adolescent
Antibodies, Bispecific administration & dosage
Antibodies, Bispecific adverse effects
Antineoplastic Agents, Immunological administration & dosage
Antineoplastic Agents, Immunological adverse effects
Child
Child, Preschool
Combined Modality Therapy
Follow-Up Studies
Hematopoietic Stem Cell Transplantation
Humans
Immunotherapy, Adoptive
Infant
Kaplan-Meier Estimate
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma diagnosis
Transplantation, Homologous
Treatment Outcome
Antibodies, Bispecific therapeutic use
Antineoplastic Agents, Immunological therapeutic use
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma drug therapy
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma mortality
Subjects
Details
- Language :
- English
- ISSN :
- 2044-5385
- Volume :
- 8
- Issue :
- 9
- Database :
- MEDLINE
- Journal :
- Blood cancer journal
- Publication Type :
- Report
- Accession number :
- 30190453
- Full Text :
- https://doi.org/10.1038/s41408-018-0117-0